Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents

Elad Moisseiev, Jolene Rudell, Eric V. Tieu, Glenn C Yiu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: To evaluate the accuracy and precision of different syringe designs for intravitreal injection of anti-VEGF agents. Methods: Volume output was measured from three syringe designs—1) 1.0 mL tuberculin syringe, 2) 1.0 mL syringe with low dead space plunger, and 3) 0.5 mL low-volume syringe—to deliver 50 µL of bevacizumab, ranibizumab, or aflibercept, each repeated four times by three different physicians for 108 total simulated injections. Volume output was calculated from difference in syringe weight before and after expelling the drug. Accuracy was determined by mean absolute percentage error (MAPE), and precision was measured by coefficient of variation (CV). Results: Volume output from all three syringes was significantly different from 50 µL, with mean volumes of 58.0 ± 5.7 µL for the tuberculin syringe, 58.0 ± 4.0 µL for the low dead space syringe, and 55.5 ± 5.1 µL for the low-volume syringe (p < 0.00001 for all). The low-volume syringe was the most accurate (MAPE = 12.8 ± 7.8% vs. 17.3 ± 9.3% or 15.9 ± 8.1%), and the low dead space syringe was the most reproducible (CV = 0.068 vs. 0.091 or 0.097). There was no significant difference in volume output between different anti-VEGF agents. Conclusions: Intravitreal injections of anti-VEGF agents using a 1.0 mL tuberculin syringe demonstrate poor accuracy and precision. A lower capacity syringe may improve accuracy, while a low dead space plunger may improve precision.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalCurrent Eye Research
DOIs
StateAccepted/In press - Mar 17 2017

Fingerprint

Intravitreal Injections
Syringes
Vascular Endothelial Growth Factor A
Tuberculin

Keywords

  • Accuracy
  • anti-VEGF
  • intravitreal injection
  • precision
  • syringe

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents. / Moisseiev, Elad; Rudell, Jolene; Tieu, Eric V.; Yiu, Glenn C.

In: Current Eye Research, 17.03.2017, p. 1-5.

Research output: Contribution to journalArticle

@article{b191efb321eb444f9ed27454d96b9ab4,
title = "Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents",
abstract = "Purpose: To evaluate the accuracy and precision of different syringe designs for intravitreal injection of anti-VEGF agents. Methods: Volume output was measured from three syringe designs—1) 1.0 mL tuberculin syringe, 2) 1.0 mL syringe with low dead space plunger, and 3) 0.5 mL low-volume syringe—to deliver 50 µL of bevacizumab, ranibizumab, or aflibercept, each repeated four times by three different physicians for 108 total simulated injections. Volume output was calculated from difference in syringe weight before and after expelling the drug. Accuracy was determined by mean absolute percentage error (MAPE), and precision was measured by coefficient of variation (CV). Results: Volume output from all three syringes was significantly different from 50 µL, with mean volumes of 58.0 ± 5.7 µL for the tuberculin syringe, 58.0 ± 4.0 µL for the low dead space syringe, and 55.5 ± 5.1 µL for the low-volume syringe (p < 0.00001 for all). The low-volume syringe was the most accurate (MAPE = 12.8 ± 7.8{\%} vs. 17.3 ± 9.3{\%} or 15.9 ± 8.1{\%}), and the low dead space syringe was the most reproducible (CV = 0.068 vs. 0.091 or 0.097). There was no significant difference in volume output between different anti-VEGF agents. Conclusions: Intravitreal injections of anti-VEGF agents using a 1.0 mL tuberculin syringe demonstrate poor accuracy and precision. A lower capacity syringe may improve accuracy, while a low dead space plunger may improve precision.",
keywords = "Accuracy, anti-VEGF, intravitreal injection, precision, syringe",
author = "Elad Moisseiev and Jolene Rudell and Tieu, {Eric V.} and Yiu, {Glenn C}",
year = "2017",
month = "3",
day = "17",
doi = "10.1080/02713683.2016.1276195",
language = "English (US)",
pages = "1--5",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents

AU - Moisseiev, Elad

AU - Rudell, Jolene

AU - Tieu, Eric V.

AU - Yiu, Glenn C

PY - 2017/3/17

Y1 - 2017/3/17

N2 - Purpose: To evaluate the accuracy and precision of different syringe designs for intravitreal injection of anti-VEGF agents. Methods: Volume output was measured from three syringe designs—1) 1.0 mL tuberculin syringe, 2) 1.0 mL syringe with low dead space plunger, and 3) 0.5 mL low-volume syringe—to deliver 50 µL of bevacizumab, ranibizumab, or aflibercept, each repeated four times by three different physicians for 108 total simulated injections. Volume output was calculated from difference in syringe weight before and after expelling the drug. Accuracy was determined by mean absolute percentage error (MAPE), and precision was measured by coefficient of variation (CV). Results: Volume output from all three syringes was significantly different from 50 µL, with mean volumes of 58.0 ± 5.7 µL for the tuberculin syringe, 58.0 ± 4.0 µL for the low dead space syringe, and 55.5 ± 5.1 µL for the low-volume syringe (p < 0.00001 for all). The low-volume syringe was the most accurate (MAPE = 12.8 ± 7.8% vs. 17.3 ± 9.3% or 15.9 ± 8.1%), and the low dead space syringe was the most reproducible (CV = 0.068 vs. 0.091 or 0.097). There was no significant difference in volume output between different anti-VEGF agents. Conclusions: Intravitreal injections of anti-VEGF agents using a 1.0 mL tuberculin syringe demonstrate poor accuracy and precision. A lower capacity syringe may improve accuracy, while a low dead space plunger may improve precision.

AB - Purpose: To evaluate the accuracy and precision of different syringe designs for intravitreal injection of anti-VEGF agents. Methods: Volume output was measured from three syringe designs—1) 1.0 mL tuberculin syringe, 2) 1.0 mL syringe with low dead space plunger, and 3) 0.5 mL low-volume syringe—to deliver 50 µL of bevacizumab, ranibizumab, or aflibercept, each repeated four times by three different physicians for 108 total simulated injections. Volume output was calculated from difference in syringe weight before and after expelling the drug. Accuracy was determined by mean absolute percentage error (MAPE), and precision was measured by coefficient of variation (CV). Results: Volume output from all three syringes was significantly different from 50 µL, with mean volumes of 58.0 ± 5.7 µL for the tuberculin syringe, 58.0 ± 4.0 µL for the low dead space syringe, and 55.5 ± 5.1 µL for the low-volume syringe (p < 0.00001 for all). The low-volume syringe was the most accurate (MAPE = 12.8 ± 7.8% vs. 17.3 ± 9.3% or 15.9 ± 8.1%), and the low dead space syringe was the most reproducible (CV = 0.068 vs. 0.091 or 0.097). There was no significant difference in volume output between different anti-VEGF agents. Conclusions: Intravitreal injections of anti-VEGF agents using a 1.0 mL tuberculin syringe demonstrate poor accuracy and precision. A lower capacity syringe may improve accuracy, while a low dead space plunger may improve precision.

KW - Accuracy

KW - anti-VEGF

KW - intravitreal injection

KW - precision

KW - syringe

UR - http://www.scopus.com/inward/record.url?scp=85015683006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015683006&partnerID=8YFLogxK

U2 - 10.1080/02713683.2016.1276195

DO - 10.1080/02713683.2016.1276195

M3 - Article

C2 - 28306392

AN - SCOPUS:85015683006

SP - 1

EP - 5

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

ER -